TY - JOUR
T1 - Stimulatory effects of chlorzoxazone, a centrally acting muscle relaxant, on large conductance calcium-activated potassium channels in pituitary GH3 cells
AU - Liu, Yen Chin
AU - Lo, Yuk Keung
AU - Wu, Sheng Nan
N1 - Funding Information:
The authors thank Hui-Fang Li, Yen-Hua Hung and Chuan-Ter Lee for their technical assistance and Professor Larry Steinrauf for editing the manuscript. The present study was funded by the National Science Council (NSC-91-2320-B075B-003) and Kaohsiung Veterans General Hospital (VGHKS90-06, VGHKS90-73), Taiwan, ROC.
PY - 2003/1/3
Y1 - 2003/1/3
N2 - Chlorzoxazone, a centrally acting muscle relaxant, has been used as a marker for hepatic CYP2E1 activity. However, little is known about the mechanism of chlorzoxazone actions on ion currents in neurons or neuroendocrine cells. We thus investigated its effects on ion currents in GH3 lactotrophs. Chlorzoxazone reversibly increased Ca2+-activated K+ current (IK(Ca)) in a concentration-dependent manner with an EC50 value of 30 μM. The chlorzoxazone-stimulated IK(Ca) was inhibited by iberitoxin (200 nM) or clotrimazole (10 μM), but not by glibenclamide (10 μM) or apamin (200 nM). Chlorzoxazone (30 μM) suppressed voltage-dependent L-type Ca2+ current. In the inside-out configuration, chlorzoxazone applied to the intracellular side of the patch did not modify single-channel conductance of large conductance Ca2+-activated K+ (BKCa) channels, but did increase channel activity by increasing mean open time and decreasing mean closed time. Chlorzoxazone also caused a left shift in the activation curve of BKCa channels. However, Ca2+-sensitivity of these channels was unaffected by chlorzoxazone. 1-Ethyl-2-benzimidazolinone (30 μM), 2-amino-5-chlorobenzoxazole (30 μM) or chlormezanone (30 μM) enhanced BKCa channel activity, while 6-hydroxychlorzoxazone (30 μM) slightly increased it; however, chlorphenesin carbamate (30 μM) had no effect on it. Under the current-clamp condition, chlorzoxazone (10 μM) reduced the firing rate of action potentials. In neuroblastoma IMR-32 cells, chlorzoxazone (30 μM) also stimulated BKCa channel activity. The stimulatory effects of chlorzoxazone on these channels may be responsible for the underlying mechanism of chlorzoxazone actions on neurons and neuroendocrine cells.
AB - Chlorzoxazone, a centrally acting muscle relaxant, has been used as a marker for hepatic CYP2E1 activity. However, little is known about the mechanism of chlorzoxazone actions on ion currents in neurons or neuroendocrine cells. We thus investigated its effects on ion currents in GH3 lactotrophs. Chlorzoxazone reversibly increased Ca2+-activated K+ current (IK(Ca)) in a concentration-dependent manner with an EC50 value of 30 μM. The chlorzoxazone-stimulated IK(Ca) was inhibited by iberitoxin (200 nM) or clotrimazole (10 μM), but not by glibenclamide (10 μM) or apamin (200 nM). Chlorzoxazone (30 μM) suppressed voltage-dependent L-type Ca2+ current. In the inside-out configuration, chlorzoxazone applied to the intracellular side of the patch did not modify single-channel conductance of large conductance Ca2+-activated K+ (BKCa) channels, but did increase channel activity by increasing mean open time and decreasing mean closed time. Chlorzoxazone also caused a left shift in the activation curve of BKCa channels. However, Ca2+-sensitivity of these channels was unaffected by chlorzoxazone. 1-Ethyl-2-benzimidazolinone (30 μM), 2-amino-5-chlorobenzoxazole (30 μM) or chlormezanone (30 μM) enhanced BKCa channel activity, while 6-hydroxychlorzoxazone (30 μM) slightly increased it; however, chlorphenesin carbamate (30 μM) had no effect on it. Under the current-clamp condition, chlorzoxazone (10 μM) reduced the firing rate of action potentials. In neuroblastoma IMR-32 cells, chlorzoxazone (30 μM) also stimulated BKCa channel activity. The stimulatory effects of chlorzoxazone on these channels may be responsible for the underlying mechanism of chlorzoxazone actions on neurons and neuroendocrine cells.
UR - http://www.scopus.com/inward/record.url?scp=0037414722&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0037414722&partnerID=8YFLogxK
U2 - 10.1016/S0006-8993(02)03730-7
DO - 10.1016/S0006-8993(02)03730-7
M3 - Article
C2 - 12480161
AN - SCOPUS:0037414722
SN - 0006-8993
VL - 959
SP - 86
EP - 97
JO - Brain Research
JF - Brain Research
IS - 1
ER -